Benzinga | Sep 17, 2020 04:07PM EDT

Sonoma Pharma, MicroSafe Report Health Canada Authorization Of Nanocyn Disinfectant, Sanitizer To Be Sold In Canada As Hard-Surface Disinfectant Under COVID-19 Interim Measure

Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, oral care, nasal care and dermatological conditions, and its partner, the MicroSafe Group, Dubai, announce that MicroSafe Group received approval by Health Canada for their patented and trademarked Nanocyn(r) Disinfectant & Sanitizer, which is manufactured by Sonoma using its patented Microcyn(r) Technology, to be sold into Canada through an interim measure for disinfectants and hand sanitizers.

Recently, Sonoma and MicroSafe Group announced that Nanocyn(r) Disinfectant & Sanitizer was approved and entered into the Australian Register of Therapeutic Goods (ARTG) for use against SARS-CoV2 (COVID-19). Nanocyn Disinfectant & Sanitizer now received authorization in Canada under the interim measure promulgated by Health Canada and may be sold into Canada with the same claim. This interim measure will be lifted by Health Canada when the regular supply stabilizes.

"Combined with the Australian COVID-19 approval as a surface disinfectant, and now the Health Canada interim measure approval, Nanocyn Disinfectant & Sanitizer is quickly establishing its place as a trusted disinfectant solution worldwide. In addition, we are pleased to announce that Nanocyn has met the stringent environmental health and social/ethical criteria of Good Environmental Choice Australia (GECA), becoming one of the very few eco-certified, all-natural disinfectant solutions in Australia. We are eager to begin distribution into Canada and start playing a role in curbing the spread of infectious disease, as we have in Australia, Europe and the Middle East," said Mrs. Safa Qadumi, Founder and CEO of the MicroSafe Group Dubai.

"We are pleased to work with our partners around the world to introduce products that create safer environments and improve the quality of life. Microcyn(r) Technology continues to see wide acceptance and use throughout the world. We are building a pipeline of products to meet the growing demand for safe, non-irritating products that help protect against viruses, bacteria and fungi," said Amy Trombly, CEO of Sonoma Pharmaceuticals.